Dare Bioscience Inc. will host a live webinar titled "The DARE to PLAY Difference" on Monday, November 17, 2025. At the event, the company will present DARE to PLAY Sildenafil Cream, a first-of-its-kind topical sildenafil formulation designed for women to enhance genital blood flow and arousal response, and discuss its clinical data and upcoming commercial availability.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dare Bioscience Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9573066-en) on November 11, 2025, and is solely responsible for the information contained therein.